Skip to main content
Log in

Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss

European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Cite this article

Abstract

This study evaluated the effectiveness of vitamins A, C, and E, with selenium, in the treatment of idiopathic sudden sensorineural hearing loss (ISSNHL). This was a prospective, controlled study performed at a tertiary teaching and research hospital. Over a 32-month period, patients were treated with either our standard ISSNHL treatment regimen plus vitamins A, C, and E and selenium (ACE+ group) or with only our standard ISSNHL treatment regimen (ACE− group). The demographics, additional symptoms, mean initial and final hearing levels, mean hearing gain, and recovery data were compared between the two groups. The ACE+ group, consisting of 70 (55.5 %) patients, received vitamin A (natural beta-carotene, 26,000 IU), vitamin C (ascorbic acid, 200 mg), vitamin E (d-alpha-tocopherol, 200 IU), and selenium (50 μg) twice daily for 30 days in addition to our ISSNHL treatment regimen: methylprednisolone at an initial dose of 1 mg/kg body weight per day, tapered over 14 days; Rheomacrodex® [(10 g of dextran and 0.9 g of NaCl)/100 ml] 500 ml daily for 5 days; Vastarel® 20-mg tablet (20 mg of trimetazidine dihydrochloride) three times daily for 30 days; and ten 60-min hyperbaric oxygen (HBO) sessions (2.5 absolute atmospheres of 100 % O2), once daily, starting the day of hospitalization. The ACE− group comprised 56 (44.4 %) patients, who received only our ISSNHL treatment regimen. The mean hearing gains were 36.2 ± 20.3 dB in the ACE+ group and 27.1 ± 20.6 dB in the ACE− group. The mean hearing gain rates were significantly higher in the ACE+ group than in the ACE− group (p = 0.014). Treatment with vitamins A, C, and E and selenium was effective in ISSNHL patients undergoing treatment with methylprednisolone, dextran, trimetazidine dihydrochloride, and HBO, and might be more effective when the initial hearing level is below 46 dB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Hughes GB, Freedman MA, Haberkamp TJ, Guay ME (1996) Sudden sensorineural hearing loss. Otolaryngol Clin North Am 29(3):393–405

    CAS  PubMed  Google Scholar 

  2. Fetterman BL, Saunders JE, Luxford WM (1996) Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol 17(4):529–536

    CAS  PubMed  Google Scholar 

  3. Whitaker S (1980) Idiopathic sudden hearing loss. Am J Otol 1(3):180–183

    CAS  PubMed  Google Scholar 

  4. Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84

    Article  CAS  PubMed  Google Scholar 

  5. Rybak LP, Whitworth C, Somani S (1999) Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 109:1740–1744

    Article  CAS  PubMed  Google Scholar 

  6. Masaya T, Matti A (2004) Functional significance of nitric oxide in the inner ear. In Vivo 18:345–350

    Google Scholar 

  7. Joachims HZ, Segal J, Golz A et al (2003) Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol 24(4):572–575

    Article  PubMed  Google Scholar 

  8. Kanzaki J, Inoue Y, Ogawa K, Fukuda S et al (2003) Effect of single-drug treatment on idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx 30:123–127

    Article  PubMed  Google Scholar 

  9. Schuknecht HF, Donovan ED (1986) The pathology of idiopathic sudden sensorineural hearing loss. Arch Otorhinolaryngol 243(1):1–15

    Article  CAS  PubMed  Google Scholar 

  10. Kopke R, Allen KA, Henderson D et al (1999) A radical demise toxins and trauma share common pathways in hair cell death. Ann N Y Acad Sci 884:171–191

    Article  CAS  PubMed  Google Scholar 

  11. Schachtele SJ, Mutnal MB, Schleiss MR, Lokensgard JR (2011) Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice. J Neurovirol 17(3):201–211

    Article  PubMed Central  PubMed  Google Scholar 

  12. Ohlemiller KK, Dugan LL (1999) Elevation of reactive oxygen species following ıschemia-reperfusion in mouse cochlea observed in vivo. Audiol Neurootol 4:219–228

    Article  CAS  PubMed  Google Scholar 

  13. Clerici WJ, DiMartino DL, Prasad MR (1995) Direct effects of reactive oxygen species on cochlear outer hair cell shape invitro. Hear Res 84:30–40

    Article  CAS  PubMed  Google Scholar 

  14. Clerici WJ, Yang L (1996) Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear Res 101:14–22

    Article  CAS  PubMed  Google Scholar 

  15. Capaccio P, Pignataro L, Gaini LM et al (2012) Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 269(2):449–453

    Article  PubMed  Google Scholar 

  16. Haberkamp TJ, Tanyeri HM (1999) Management of idiopathic sudden sensorineural hearing loss. Am J Otol 20(5):587–592

    CAS  PubMed  Google Scholar 

  17. Shemirani NL, Schmidt M, Friedland DR (2009) Sudden sensorineural hearing loss: an evaluation of treatment and management approaches by referring physicians. Otolaryngol Head Neck Surg 140(1):86–91

    Article  PubMed  Google Scholar 

  18. Inna M, Barbara C (2011) Protecting the auditory system with glucocorticoids. Hear Res 281:47–55

    Article  Google Scholar 

  19. Wei BP, Stathopoulos D, O’Leary S (2013) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 7:CD003998. doi:10.1002/14651858.CD003998.pub3

    PubMed  Google Scholar 

  20. Alex B, Raoul B, Roberto C (2008) Combination therapy (ıntratympanic dexamethasone + high-dose prednisone taper) for the treatment of ıdiopathic sudden sensorineural hearing loss. Otol Neurotol 29:453–460

    Article  Google Scholar 

  21. Daisuke A, Hideki T, Shigeru K (2006) Evaluation of super-high-dose steroid therapy for sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 134:783–787

    Article  Google Scholar 

  22. Himeno C, Komeda M, Izumikawa M et al (2002) Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 167(1–2):61–70

    Article  CAS  PubMed  Google Scholar 

  23. Grundy JE (1998) Current antiviral therapy fails to prevent the pro-ınflammatory effects of cytomegalovirus ınfection, whilst rendering ınfected cells relatively resistant to ımmune attack. In: Ed Scholz M, Rabenau HF, Doerr HW, Cinatl J Jr (eds) CMV-related ımmunopathology. Monogr. Virol Basel, Karger, vol 21, pp 67–89

  24. Westerlaken BO, Stokroos RJ, Dhooge IJ et al (2003) Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol 112(11):993–1000

    Article  PubMed  Google Scholar 

  25. Suzuki H, Hashida K, Nguyen KH et al (2012) Efficacy of intratympanic steroid administration on idiopathic sudden sensorineural hearing loss in comparison with hyperbaric oxygen therapy. Laryngoscope 122:1154–1157

    Article  CAS  PubMed  Google Scholar 

  26. Bennett MH, Kertesz T, Perleth M et al (2012) Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 10:CD004739. doi:10.1002/14651858.CD004739.pub4

    PubMed  Google Scholar 

  27. Narkowicz CK, Vial JH, McCartney PW (1993) Hyperbaric oxygen therapy increases free radical levels in the blood of humans. Free Radic Res Commun 19(2):71–80

    Article  CAS  PubMed  Google Scholar 

  28. Tabuchi K, Tsuji S, Fujihira K et al (2002) Outer hair cells functionally and structurally deteriorate during reperfusion. Hear Res 173(1–2):153–163

    Article  PubMed  Google Scholar 

  29. Clarkson PM, Thompson HS (2000) Antioxidants: what role do they play in physical activity and health? Am J Clin Nutr 72(2 Suppl):637–646

    Google Scholar 

  30. Krinsky NI (1989) Antioxidant functions of carotenoids. Free Radic Biol Med 7:617–635

    Article  CAS  PubMed  Google Scholar 

  31. Joong HA, Hun HK, Young-Jin K, Jong WC (2005) Anti-apoptotic role of retinoic acid in the inner ear of noise-exposed mice. Biochem Biophys Res Commun 335:485–490

    Article  Google Scholar 

  32. Ulf-Rüdiger H, Ilka F, Jürgen B et al (2008) Ascorbic acid reduces noise-ınduced nitric oxide production in the guinea pig ear. Laryngoscope 118(5):837–842

    Article  Google Scholar 

  33. Kong WJ, Han YC, Wang Y et al (2004) Protective roles of vitamin E and coenzyme Q10 in the inner ear mitochondrial DNA 4834 bp deletion mutation of rats. Zhonghua Er Bi Yan Hou Ke Za Zhi. 39(12):707–711

    PubMed  Google Scholar 

  34. Padayatty SJ, Katz A, Wang Y et al (2003) Vitamin an antioxidant: evaluation of ıts role in disease prevention. J Am Coll Nutr 22(1):18–35

    Article  CAS  PubMed  Google Scholar 

  35. Gebicki JM, Jurgens G, Esterbauer H (1991) Oxidative stress. In: Sies H (ed) Oxidants and antioxidants. Academic Press, London, pp 371–397

    Google Scholar 

  36. Packer L (1992) Interactions and disease: among antioxidants in health vitamin E and its redox cycle. Proc Soc Exp Biol Med 200(2):271–276

    Article  CAS  PubMed  Google Scholar 

  37. Seidman MD (2000) Effects of dietary restriction and antioxidants on presbyacusis. Laryngoscope 110(5 Pt 1):727–738

    Article  CAS  PubMed  Google Scholar 

  38. Chance B, Sies H, Boveris A (1979) Hydroperoxide metabolism in mammalianorgans. Physiol Rev 59(3):527–605

    CAS  PubMed  Google Scholar 

  39. Heinrich UR, Brieger J, Stauber RH, Mann WJ (2011) Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss. HNO 59(11):1103–1110

    Article  PubMed  Google Scholar 

  40. Henry Z, Joachims JS, Avishay G et al (2003) Antioxidants in treatment of ıdiopathic sudden hearing loss. Otol Neurotol 24:572–575

    Article  Google Scholar 

  41. Salganik RI (2001) The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 20(5 Suppl):464–472 (discussion 473–475)

    Article  Google Scholar 

  42. Miyako H, Naoki U, Yozo O et al (2008) Vitamin E and vitamin C in the treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol 128:116–121

    Article  Google Scholar 

  43. Chao-Hui Y, Ming-Tse K, Jyh-Ping P, Chung-Feng H (2011) Zinc in the treatment of ıdiopathic sudden sensorineural hearing loss. Laryngoscope 121:617–621

    Article  Google Scholar 

  44. Office of Dietary Supplements (2013) National Institutes of Health. Vitamin and mineral supplement fact sheets. http://ods.od.nih.gov/factsheets/listVitaminsMinerals. Accessed 26 Sept 2013

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hakan Kaya.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kaya, H., Koç, A.K., Sayın, İ. et al. Vitamins A, C, and E and selenium in the treatment of idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 272, 1119–1125 (2015). https://doi.org/10.1007/s00405-014-2922-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-014-2922-9

Keywords

Navigation